Outpace Bio (Series A)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$150,000,000

Company Info
Founders
Marc Lajoie
Company Description
Tailored cell therapy solutions through protein design and custom programming. Outpace Bio is a biotechnology company that is revolutionizing cell therapy with protein design.
Market
Healthcare & Wellness
Coinvestors
Playground Global

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement